NuScale Power Shares Rise 7% on Narrower Q2 Loss, Revenue Up Y/Y

NuScale Power (SMR) reported mixed Q2 2025 results, with revenue surging 733% year-over-year to $8.1 billion, driven by the RoPower project, and a narrower loss per share of 13 cents; both figures, however, missed consensus estimates. Despite the financial misses, shares gained 7.2% following the report, primarily propelled by the early NRC approval for its 77 MWe SMR design, solidifying its unique regulatory position as the only SMR technology with two NRC approvals and underscoring a significant long-term catalyst for the company's market viability.

Analysis

NuScale Power's second-quarter 2025 results present a dual narrative of significant strategic progress against a backdrop of mixed financial execution. The market's positive reaction, with shares gaining 7.2%, was primarily driven by a key regulatory milestone—the early NRC approval for its 77 MWe SMR design—which solidifies its position as the only company with two such approvals and provides a considerable competitive moat. This was coupled with extraordinary top-line growth, as revenues surged 733% year-over-year to $8.1 billion, fueled by fees from the RoPower project. Despite this, the company missed analyst consensus on both revenue and earnings per share by 11.15% and 8.33%, respectively. While the reported loss per share narrowed to 13 cents from 31 cents a year prior, operational metrics indicate rising costs. The operating loss widened slightly to $43.08 million, and general & administrative expenses increased 33.8% year-over-year. A significant concern is the cash burn rate; cash and short-term investments declined by approximately $100 million in the quarter to $420.7 million, a material reduction that underscores the capital-intensive nature of its current growth phase. The outlook for Q3 reflects this dichotomy, with analysts forecasting a 2,260% year-over-year revenue increase but also a swing to a loss of 11 cents per share from a profit in the prior-year quarter.

Key Decisions for Investors

• Investors with a higher risk tolerance may focus on the significant long-term catalyst of the dual NRC approvals, which creates a strong competitive barrier and validates the technology's commercial path, potentially overshadowing the near-term earnings miss.
• It is critical to monitor the company's cash burn, as the $100 million quarterly decrease in cash and equivalents could become a significant headwind if not offset by sustained revenue growth and improved cost controls.
• Given that Q2 revenue and EPS missed estimates, investors should scrutinize upcoming results to confirm the company can meet the high expectations set by the Q3 revenue growth forecast of 2,260% and manage its transition from profitability to a projected loss.